Event: BTOG 2024

0:00:44

BTOG 2024: networking highlights and insights

0:03:18

Key insights from BTOG 2024: MARS 2 and HIT-MESO

0:03:03

BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies

0:02:53

BTOG Conference 2024 - Case Study

0:01:04

BTOG 2024 highlights: MARS 2 trial on mesothelioma surgery and TRACERx on lung cancer evolution

0:02:33

Reflecting on BTOG 2024: networking and multidisciplinary collaboration

0:04:20

Insights from BTOG 2024: advancements in TNM staging, systematic staging, & immunotherapy strategies

0:01:45

Exploring novel therapeutics in lung cancer: insights from BTOG 2024

0:00:54

Ongoing lung cancer trials and the potential of Trop2 biomarker at BTOG 2025

0:02:28

State of the Nation 2024 report: promising trends & challenges in lung cancer diagnosis & treatment

0:01:14

Addressing challenges in collecting cardiac toxicity data: NI-HEART analysis

0:25:46

2024: Meet the Farm (and newbies), Ren's health problems, Tog Spot Good Stuff and more!

0:00:43

Advancements in stent technology for treating central airway obstruction

0:01:08

Personalized treatment planning for lung cancer with interstitial lung disease

0:00:49

Ongoing trials in thoracic radiotherapy: evaluating current role and significance

0:02:08

Managing lung cancer in ILD patients and implementing ctDNA testing in the NHS

0:02:10

Is there a role for radiotherapy in extensive-stage SCLC?

0:03:08

NI-HEART study results: cardiotoxicity after lung cancer radiotherapy

0:00:45

Assessing treatment options for lung cancer with interstitial lung disease

0:01:11

Addressing malignant central airway obstruction

0:01:33

Implementing liquid biopsies: advancing lung cancer care in the UK

0:00:37

STABLE-MATES: sublobar resection vs SAbR in high-risk patients with stage I NSCLC

0:01:44

Managing lung cancer patients with ILD: the oncology perspective

0:00:53

Assessing vaccine delivery in lung cancer care